World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
38468
World Ranking
10361
National Ranking
5329

Overview

Julie A. Johnson is affiliated with the University of Florida in the United States. Their research primarily spans the field of Medicine, with significant contributions in Pharmacology, Cardiology and Cardiovascular Medicine, Surgery, Pediatrics, Perinatology and Child Health, as well as Endocrinology, Diabetes and Metabolism.

Their scholarly work includes a focus on several main topics:

  • Pharmacogenetics and Drug Metabolism
  • Pharmaceutical studies and practices
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Health Systems, Economic Evaluations, Quality of Life
  • Genetic Associations and Epidemiology
  • Diabetes Treatment and Management
  • Pain Management and Opioid Use

Recent publications authored or co-authored by Julie A. Johnson include:

  • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing, 2020, Clinical Pharmacology & Therapeutics
  • Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality, 2021, European Heart Journal
  • How to Integrate CYP2D6 Phenoconversion Into Clinical Pharmacogenetics: A Tutorial, 2021, Clinical Pharmacology & Therapeutics
  • Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing, 2021, Genetics in Medicine
  • Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention, 2020, Clinical Pharmacology & Therapeutics

The frequent co-authors collaborating with Julie A. Johnson include:

  • Larisa H. Cavallari
  • Yan Gong
  • Caitrin W. McDonough
  • Rhonda M. Cooper-DeHoff
  • Amber L. Beitelshees

Key venues where Julie A. Johnson has published include:

  • Clinical Pharmacology & Therapeutics
  • Clinical and Translational Science
  • UNC Libraries
  • Genetics in Medicine
  • bioRxiv (Cold Spring Harbor Laboratory)

Julie A. Johnson also contributed to book publications, notably with the University of Salford on the volume titled SPARC 2021 - Against all odds: Salford postgraduate annual research conference book of abstracts published in 2021.

Best Publications

  • Estimation of the warfarin dose with clinical and pharmacogenetic data

    Klein Te;Altman Rb;Eriksson N

  • Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells

    Jonathan S Draper;Kath Smith;Paul Gokhale;Harry D Moore

  • Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update

    Scott Sa;Sangkuhl K;Stein Cm;Hulot Js;Hulot Js

  • Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

    BF Gage;C Eby;JA Johnson;E Deych

  • A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing

    Stephen E. Kimmel;Benjamin French;Scott E. Kasner;Julie A. Johnson

  • Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing

    J. A. Johnson;L. Gong;M. Whirl-Carrillo;B. F. Gage

  • CYP4F2 genetic variant alters required warfarin dose.

    Michael D. Caldwell;Tarif Awad;Julie A. Johnson;Brian F. Gage

  • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.

    JA Johnson;KE Caudle;L Gong;M Whirl-Carrillo

  • Pharmacogenomics: the inherited basis for interindividual differences in drug response.

    William E. Evans;Julie A. Johnson

  • Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450–2C19 (CYP2C19) Genotype and Clopidogrel Therapy

    SA Scott;K Sangkuhl;EE Gardner;CM Stein

  • A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

    Gregory M. Cooper;Julie A. Johnson;Taimour Y. Langaee;Hua Feng

  • Preserving the genetic integrity of human embryonic stem cells.

    Maisam M Mitalipova;Raja R Rao;Deborah M Hoyer;Julie A Johnson

  • Human embryonic stem cells derived without feeder cells

    Irina Klimanskaya;Young Chung;Lorraine Meisner;Julie Johnson

  • Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

    Nita A. Limdi;Mia Wadelius;Larisa Cavallari;Niclas Eriksson

  • β1-Adrenergic Receptor Polymorphisms and Antihypertensive Response to Metoprolol

    Julie A. Johnson;Issam Zineh;Brian J. Puckett;Susan P. McGorray

  • Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements

    Christina L. Aquilante;Taimour Y. Langaee;Larry M. Lopez;Hossein N. Yarandi

  • Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas

    J. A. Johnson;Joseph Peter Grande;P. C. Roche;Rajiv Kumar

  • Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.

    T A Waldmann;J D White;J A Carrasquillo;J C Reynolds

  • Impact of genetic polymorphisms of the β2-adrenergic receptor on albuterol bronchodilator pharmacodynamics

    John J. Lima;Donald B. Thomason;Mohamad H.N. Mohamed;Louis V. Eberle

  • Use of Pharmacogenetics and Clinical Factors To Predict the Maintenance Dose of Warfarin.

    B. F. Gage;C. S. Eby;J. A. Johnson;M. J. Rieder

Frequent Co-Authors

Arlene B. Chapman
Arlene B. Chapman University of Chicago
Eric Boerwinkle
Eric Boerwinkle The University of Texas Health Science Center at Houston
Carl J. Pepine
Carl J. Pepine University of Florida
Alan R. Shuldiner
Alan R. Shuldiner University of Maryland, Baltimore
Kent R. Bailey
Kent R. Bailey Mayo Clinic
Teri E. Klein
Teri E. Klein Stanford University
Nilesh J. Samani
Nilesh J. Samani University of Leicester
Paul I. W. de Bakker
Paul I. W. de Bakker Vertex Pharmaceuticals (United Kingdom)
Winfried März
Winfried März Medical University of Graz

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees online can open up additional pathways for those interested in Medicine in the USA. Many students pursue administrative leadership roles by enrolling in cahme accredited mha online programs, focusing on healthcare management rather than clinical care.

If you hold a nursing license, there are now flexible rn bsn online programs no clinicals required. These programs are ideal for working nurses seeking to upgrade their credentials without traditional on-site requirements.

For those aspiring to advanced nursing practice at the doctorate level, options like the shortest online dnp program allow for accelerated completion. Some universities also offer the 1 year dnp program online for experienced nurses wanting to advance quickly.

These diverse online pathways present greater flexibility, enabling students from varied backgrounds to enter or advance in healthcare fields without traditional barriers. Each option supports a unique career goal in the broader medical landscape.

Best Scientists Citing Julie A. Johnson

Trending Scientists